alanine has been researched along with enalaprilat anhydrous in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bird, JE; Waldron, TL | 1 |
| Fox, M; Panchal, BC; Trippodo, NC | 1 |
| Asaad, MM; Dorso, CR; Fox, M; Natarajan, V; Panchal, BC; Trippodo, NC | 1 |
| Brovkovych, V; Erdös, EG; Ignjatovic, T; Skidgel, RA; Tan, F | 1 |
4 other study(ies) available for alanine and enalaprilat anhydrous
| Article | Year |
|---|---|
Endogenous synthesis of endothelin-1 may mediate a delayed pressor response after injection of endothelin-1 in rats.
Topics: Alanine; Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Enalaprilat; Endothelin Receptor Antagonists; Endothelins; Fatty Acids, Unsaturated; Glycopeptides; Hydrazines; Injections, Intravenous; Male; Peptides, Cyclic; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane | 1995 |
Repression of angiotensin II and potentiation of bradykinin contribute to the synergistic effects of dual metalloprotease inhibition in heart failure.
Topics: Alanine; Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Blood Volume; Bradykinin; Cricetinae; Drug Synergism; Enalaprilat; Heart Failure; Irbesartan; Male; Neprilysin; Tetrazoles; Vasodilation; Ventricular Function, Left | 1995 |
Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure.
Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomyopathies; Cricetinae; Drug Synergism; Enalaprilat; Hemodynamics; Kidney; Male; Neprilysin | 1993 |
Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor.
Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Binding Sites; Binding, Competitive; Calcium; Cell Line; Chelating Agents; CHO Cells; COS Cells; Cricetinae; DNA, Complementary; Dose-Response Relationship, Drug; Edetic Acid; Enalaprilat; Endothelium, Vascular; Enzyme Inhibitors; Fibroblasts; Histidine; Humans; Ligands; Lysine; Mutagenesis, Site-Directed; Nitric Oxide; Protein Binding; Protein Structure, Tertiary; Receptor, Bradykinin B1; Receptors, Bradykinin; Transfection; Zinc | 2002 |